Ziopharm Oncology reported $32.87M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 14.33B 1.71B
AstraZeneca AZN:LN USD 24.85B 3.04B
Baxter International BAX:US USD 3.71B 208M
Biogen BIIB:US USD 3.93B 1.09B
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Corcept Therapeutics CORT:US USD 53.07M 4.01M
Curis CRIS:US USD 13.74M 1.59M
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Immunogen IMGN:US USD 103.64M 16.57M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Intrexon XON:US USD 104.86M 74.96M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Novartis NOVN:VX USD 28.16B 514M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Roche Holding ROG:VX 27.41B 11.01B
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Tg Therapeutics TGTX:US USD 36.45M 6.88M
Verastem VSTM:US USD 21.87M 1.78M
YTE INCY:US USD 1.01B 79.92M
Ziopharm Oncology ZIOP:US USD 32.87M 6.09M